Royalty Pharma Plc (RPRX) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: GB00BMVP7Y09

Cancer, Neuroscience, Immunology, Respiratory, Infectious Disease, Hematology, Diabetes

Royalty Pharma plc is a pioneering company that specializes in buying biopharmaceutical royalties and funding innovative projects in the biopharmaceutical industry in the United States.

The company's primary focus is on identifying, evaluating, and acquiring royalties on various biopharmaceutical therapies, which enables it to build a diverse portfolio of products and candidates.

Royalty Pharma plc collaborates with a wide range of partners, including academic institutions, research hospitals, not-for-profit organizations, small and mid-cap biotechnology companies, and pharmaceutical companies, to drive innovation and advance medical research.

The company's portfolio is impressive, consisting of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, including rare diseases, cancer, neuroscience, immunology, respiratory, infectious diseases, hematology, and diabetes.

Founded in 1996, Royalty Pharma plc is headquartered in New York, New York, and has established itself as a leader in the biopharmaceutical industry, with a strong commitment to funding innovation and improving patient outcomes.

For more information, please visit their website at https://www.royaltypharma.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Royalty Pharma Plc (RPRX) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Royalty Pharma Plc (RPRX) - Stock Price & Dividends

RPRX Stock Overview

Market Cap in USD 16,406m
Sector Healthcare
Industry Biotechnology
GiC SubIndustry Pharmaceuticals
TER 0.00%
IPO / Inception 1993-03-25

RPRX Stock Ratings

Growth 5y -16.2
Fundamental 15.8
Dividend 6.86
Rel. Performance vs Sector -2.42
Analysts 4.44/5
Fair Price Momentum 24.48 USD
Fair Price DCF 93.35 USD

RPRX Dividends

Yield 12m 3.05%
Yield on Cost 5y 3.18%
Dividends CAGR 5y 7.46%
Payout Consistency 100.0%

RPRX Growth Ratios

Growth 12m -10.51%
Growth Correlation 12m -11%
Growth Correlation 3m -65%
CAGR 5y 1.05%
CAGR/Mean DD 5y 0.04
Sharpe Ratio 12m -0.68
Alpha vs SP500 12m -34.86
Beta vs SP500 5y weekly 0.86
ValueRay RSI 45.40
Volatility GJR Garch 1y 21.49%
Price / SMA 50 -2%
Price / SMA 200 -3.44%
Current Volume 3209.4k
Average Volume 20d 2770.7k

External Links for RPRX Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of RPRX stocks?
As of June 22, 2024, the stock is trading at USD 26.91 with a total of 3,209,379 shares traded.
Over the past week, the price has changed by -0.04%, over one month by -0.96%, over three months by -10.90% and over the past year by -10.59%.
What are the forecast for RPRX stock price target?
According to ValueRays Forecast Model, RPRX Royalty Pharma Plc will be worth about 26.8 in June 2025. The stock is currently trading at 26.91. This means that the stock has a potential downside of -0.59%.
Issuer Forecast Upside
Wallstreet Target Price 43.8 62.9
Analysts Target Price 48.7 80.9
ValueRay Target Price 26.8 -0.59